%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% - Desempenho dos modelos supervisionados
% - Comparação entre modelos discriminativos e espaço latente
% - Impacto da integração dos dados clínicos
% - Resultado da abordagem alternativa
% - Interpretação biológica
% - Discussão limitações
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

\typeout{NT FILE chapter5.tex}%
\chapter{Results and Discussion}
\label{cha:results_and_discussion}

\section{Comparative Performance}\
Discussion on how model performance evolved from the small dataset to the large dataset (did it generalize better?).

\section{miRNA Biomarker Evaluation}
Consistency of "important" miRNAs across different models.

Are these miRNAs known in literature, or are they novel candidates for personalized medicine?

\section{Practical Implications for Clinicians}
How these models can aid in faster, data-driven subtyping.

\section{Limitations of the Study}
Data imbalance, biological noise in miRNA, etc.